Natalie’s Commentary: Is it a coincidence that currently the largest shortages of baby formula is now occurring when Bill Gates has invested in a company Biomilq, a North Carolina-based start-up that’s targeting infant nutrition by attempting to reproduce mother’s breast milk in a lab. Could parents trust Bill Gates simulated breast milk given to their infants fragile immunity systems? After all, Gates track record for giving millions upon millions of vaccine doses to people and children in Africa has claimed the lives of millions under the Melinda and Bill Gates Foundation which provided free vaccines. Gates was also an integral part of the experimental genetic altering shots, deceptively called “vaccines”, without going through gold standard trials, stopping and addressing the 100s of dangerous adverse events occurring in the human body and even deaths. Gates extremely close ties to the Chinese Communist regime doesn’t necessarily put him in an objective position to not to continue to harm more Americans for the sake of the Chinese genocidal communist party. I think it should disqualify him from having any part of participating in people’s health, recovery, healing and especially vaccines. Gates practically owns all of the drug companies, Big Pharma in the US. ~ Natalie
Beyond Meat and Impossible Foods are two of the best-known companies disrupting the food sector.
Now, the pipeline of alt-food companies includes Biomilq, a North Carolina-based start-up that’s targeting infant nutrition by attempting to reproduce mother’s breast milk in a lab.
While that may seem like a moon shot, Biomilq has just earned the backing of the world’s top investors, raising $3.5 million in Series A funding from Breakthrough Energy Ventures, Bill Gates’ investment firm focused on climate change.
Breakthough Ventures’ investing coalition includes Jeff Bezos, Mark Zuckerberg, Richard Branson, Masayoshi Son, Jack Ma, Michael Bloomberg and Marc Benioff.
Bill Gates’ climate-change investment firm bets on lab-produced breast milk
From CNBC By Aditi Roy June 16, 2020
Biomilq co-founder and CEO Michelle Egger is a food scientist who worked on the Larabar at General Mills before moving onto business school and a stint at the Gates Foundation. She and her co-founder, CSO Leila Strickland, hope that the breast milk produced by Biomilq from culturing mammary epithelial cells will help reduce the carbon footprint from the global infant formula market, which Fortune Business Insights says will surpass $103 billion by 2026. The top infant formula manufacturers include Abbott Labs, Danone and Nestle.
“Right now, by the estimations we have been able to make, at least 10% of the dairy market globally ends up in infant formula,” Eggers said. “That means per-infant-fed formula in the U.S., 5,700 metric tons of CO2 are produced, and 4,300 gallons of freshwater are consumed each year to feed a child. Parents want to do what’s best for their kids but shouldn’t have to decide between feeding their children and protecting the planet.”
For Strickland, the journey has been more personal. She struggled to breastfeed her son when he was born prematurely.